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Introduction
infections have increasingly emerged in nosocomial settings and are problematic because they 135 encode multidrug resistance (MDR) mechanisms, which limits treatment options (33, [35] [36] [37] . 136
Alternative last-line therapeutics used to treat MDR Gram-negative infections include the 137 CAMP, colistin (polymyxin E), which binds the lipid A portion of LPS to perturb the outer 138 membrane and lyse the bacterial cell. Despite the success of colistin treatment as a last-line 139 therapeutic to combat Gram-negative infections (38, 39), many ECC clusters demonstrated 140 heteroresistance, where a subset of the clonal population is colistin resistant (35, (40) (41) (42) . We do 141 not fully understand the underlying molecular mechanism(s) that regulate colistin 142 heteroresistance in ECC; further characterization will advance our understanding of 143 antimicrobial resistance and could help improve treatment strategies. 144
Previous reports showed that colistin heteroresistance naturally occurs within clonal ECC 145 clusters, including E. cloacae (cluster XI) (35) . Moreover, colistin heteroresistance in E. cloacae 146 was induced by innate immune defenses within a murine infection model to lead to treatment 147 failure (40). Transcriptional analysis of susceptible and resistant populations suggested that pEtN 148 and L-Ara4N lipid A modifications contribute to heteroresistance (40) and PhoPQ contributed to 149 regulation (35, 40) , as described in other Enterobacteriaceae (5). However, it was not established 150 that the lipid A modifications actually occur, nor has PhoPQ-dependent, PmrAB-independent 151 regulation of colistin heteroresistance been fully described in E. cloacae or other ECC isolates. 152
Herein, we demonstrate that E. cloacae colistin heteroresistance is directly regulated by 153 PhoPQ Ecl to induce L-Ara4N modification of lipid A. In contrast, many other Enterobacteriaceae 154 directly regulate L-Ara4N modification of lipid A via the PmrAB TCS. The PhoP Ecl response 155 regulator directly binds to the promoter region of arnB Ecl , which is the first gene of a seven-gene 156 operon (arnBCADTEF Ecl ). In contrast, PhoP Ecl does not bind the arnB promoter region in E. coli.
Transcriptomics analysis supports a model of PhoPQ-dependent, PmrAB-independent arn Ecl 158 regulation. Furthermore, L-Ara4N modification of lipid A increased in response to growth in 159 limiting Mg 2+ , which induced colistin resistance in a PhoPQ 161
Results 162
Colistin heteroresistance in E. cloacae is regulated by PhoPQ Ecl , but not PmrAB Ecl . 163 To elucidate the underlying mechanisms that regulate colistin heteroresistance in ECC, we 164 analyzed a collection of E. cloacae subsp. cloacae strain ATCC 13047 genetic mutants by 165 calculating the colony forming units (CFUs) during exponential growth in the absence and 166 presence of colistin ( Fig 1A) . While wild type and all mutant E. cloacae strains grew in standard 167 growth media, ∆phoPQ Ecl was not viable when 10 µg/ml of colistin was added to the media. 168
Clinical resistance to colistin is defined as >4 µg/ml (43) . The decrease in ∆phoPQ Ecl cell 169 viability suggested that PhoPQ Ecl signaling is required for colistin heteroresistance. Interestingly, 170 viability was not altered when the ∆pmrAB Ecl mutant was grown in colistin, which implied that 171 PmrAB Ecl does not regulate colistin heteroresistance. Furthermore, wild type E. cloacae grown in 172 colistin demonstrated approximately ten-fold less CFUs at hour two (P value <0.05), suggesting 173 that there was a survival defect in early logarithmic growth phase. However, the fitness defect 174 was no longer significant at hour three and by hour four, CFUs were equivalent to growth 175 without colistin ( Fig 1A) . 176
Due to reports of colistin heteroresistance in E. cloacae and other ECC strains (35, 40) , 177 we subjected wild type, ∆phoPQ Ecl , ∆phoPQ Ecl /pPhoPQ Ecl , and ∆pmrAB Ecl E. cloacae to colistin ∆phoPQ Ecl /pPhoPQ Ecl , and ∆pmrAB Ecl strains, but not ∆phoPQ Ecl . We confirmed colistin 181 heteroresistance using population analysis profiling (PAP) ( Table 1) . Minimal inhibitory 182 concentration (MIC) values were calculated using the broth microdilution (BMD) method (Table  183   1 Since lipid A modifications induce colistin resistance in pathogenic Enterobacteriaceae 189 (5), we analyzed wild type and mutant E. cloacae lipid A for modifications. 32 P-radiolabelled 190 lipid A was isolated and chromatographically separated based on hydrophobicity. As controls, 191 we also analyzed lipid A from E. coli strain W3110 ( Fig 1B, lane 1) , which does not significantly 192 modify its lipid A, and strain WD101( Fig 1B, lane 9) , which constitutively expresses pmrA to 193 produce modified lipid A (19). Thin layer chromatography (TLC) analysis indicated that wild 194 type E. cloacae produced a mixture of lipid A consistent with modified and unmodified species 195 ( Fig 1B, lane 2) . ∆phoPQ Ecl and the ∆arn Ecl strains did not produce modified lipid A (Fig 1B, 196 lanes 3 and 8). PhoPQ complementation fully restored production of modified lipid A in the 197 phoPQ mutant ( Fig 1B, lane 4) . Furthermore, site-directed mutagenesis to substitute H277 in 198 PhoQ Ecl or D57 in PhoP Ecl with alanine limited lipid A assembly to only unmodified species (Fig 199 1B lanes 5 and 6). These results confirm that PhoPQ Ecl assembled a modified lipid A, similar to wild type ( Fig 1B, lane 7) , and exhibited colistin 206 heteroresistance ( Fig 1A, Table 1 , Fig S1A) , suggesting that PmrAB Ecl The lipid A anchor of LPS is a pathogen associated molecular pattern (PAMP) that is 211 bound with high affinity by the mammalian host TLR-4/MD-2 complex (45), which activates a 212 proinflammatory response to clear the bacterial infection (46). Structural alterations to lipid A 213 can dramatically alter TLR-4/MD-2-dependent host immune activation (2) and a previous report 214 nicely demonstrated that E. cloacae colistin heteroresistance was induced by innate immune 215 effectors (40). Therefore, we examined if E. cloacae containing modified or unmodified lipid A 216 would differentially activate TLR-4/MD-2 in a human embryonic kidney reporter cell line 217 (HEK-blue) (2). Wild type and phoPQ Ecl mutant strains stimulated TLR-4/MD-2-dependent 218 activation equally ( Fig S1B) , suggesting that lipid A modifications do not significantly alter host 219 immune recognition. Reporter activation by E. cloacae lipid A was attenuated compared to E. 220 coli lipid A at higher cell densities, suggesting differential recognition by the human TLR-4/MD-221 2 complex. The Gram-positive Staphylococcus aureus did not produce lipid A and did not 222 stimulate the TLR-4/MD-2 complex ( Fig S1B) . Thus, while PhoPQ Ecl -dependent lipid A 223 modifications contribute to CAMP resistance in E. cloacae, they do not significantly affect 224 innate immune recognition and reactivity. 225
Determination of E. cloacae lipid A modifications. 227
In order to define outer membrane modifications in E. cloacae, we isolated lipid A from wild 228 type and ∆phoPQ Ecl . Purified lipid A was analyzed by direct infusion nanoESI. The MS1 spectra 229 with a range of m/z 750-2000 are shown in Figure S2 the phoPQ Ecl mutant demonstrated that palmitate addition at the R-2-hydroxymyristate position 244 of lipid A occurred independent of PhoPQ Ecl (Fig S6) . 245
Based on transcriptomics studies, a previous report suggested that E. cloacae adds pEtN 246 and L-Ara4N to lipid A to develop colistin heteroresistance (40). However, our genetic and high 247 resolution mass spectrometry analysis demonstrate that only L-Ara4N modifies the 1-and 4'-modification correlates with colistin heteroresistance ( Fig 1A and Table 1) . 250 251 L-Ara4N lipid A modifications are dependent on PhoPQ Ecl , but not PmrAB Ecl . 252 To further characterize lipid A modifications in the ∆pmrAB Ecl mutant, we analyzed purified 253 lipid A using MALDI-TOF mass spectrometry. While wild type E. cloacae produced a lipid A 254 mixture, which included L-Ara4N modified lipids ( Fig S7A and B) , analysis of ∆phoPQ Ecl and 255 ∆arn Ecl indicated that L-Ara4N modified lipid A were not present. Expression of PhoPQ Ecl in 256 trans restored L-Ara4N modified lipid A in the phoPQ Ecl mutant. Importantly, ∆pmrAB Ecl 257 produced the L-Ara4N modification, similar to wild type ( Fig S7A) . The m/z of each prominent 258 peak in our MALDI-MS analysis corresponded with the exact mass of an expected structure with 259 only the L-Ara4N-containing structures demonstrating colistin resistance ( Fig S7B) . Here, we 260 confirmed that L-Ara4N modification of lipid A in E. cloacae is not dependent on PmrAB Ecl . 261 262
PhoP Ecl directly binds to the arnB Ecl promoter. 263
The arn operon is composed of seven genes and expression is driven by a promoter upstream of 264 arnB (20). This genetic organization is conserved in E. cloacae as illustrated in Fig 3A. phoP 265 expression is autoregulated in Enterobacteriaceae, where PhoP binds to the PhoP box where it 266 interacts with RNA polymerase to induce transcription (47). The putative PhoP box in the phoP 267 promoter region (P phoP ) is conserved in E. coli, Salmonella, and E. cloacae ( Fig 3B) . Alignment 268 of the E. cloacae arnB promoter region (P arnB ) with E. coli, Salmonella, and E. cloacae P phoP 269 suggested a putative PhoP box region. Importantly, E. cloacae P arnB , which encodes a putative 270 PhoP box, is highly conserved among ECC. However, this feature was not encoded within E. 271 coli P arnB , suggesting that regulatory mechanisms that control promoter activation are different ( Fig 3B) . 273
We performed electrophoretic mobility shifts (EMSAs) using E. cloacae P arnB to 274 determine if PhoP Ecl directly binds the promoter to activate arn Ecl transcription. Increasing 275 concentrations of purified PhoP Ecl (Fig S8) induced a shift of the biotinylated arnB Ecl promoter 276 fragment, which contains the putative PhoP box binding motif ( Fig 3C) . Importantly, PhoP Ecl 277 does not bind to E. coli P arnB , which does not encode the PhoP box motif ( Fig 3C) . Furthermore, 278
the PhoP Ecl -arnB Ecl promoter interaction was abrogated when unlabeled E. cloacae P arnB was 279 added in increasing ratios, as a competitive inhibitor. We also show that the interaction is 280 specific because addition of noncompetitive DNA (poly dI-dC) did not reduce the PhoP Ecl and E. 281 cloacae P arnB interaction ( Fig 3D) . Lastly, PhoP Ecl bound E. cloacae and E. coli P phoP , which both 282 encode the nucleotide sequence specific to the PhoP box ( Fig 3E) . Together, these findings 283
suggest that E. cloacae encodes a mechanism that enables L-Ara4N biosynthesis to respond 284 directly to PhoPQ Ecl . 285
286

RNA-sequencing analysis of the phoPQ Ecl and pmrAB Ecl mutants. 287
To better understand the PhoP Ecl and PmrAB Ecl regulatory products, we isolated and sequenced 288 total RNA from wild type and mutant E. cloacae strains. A heat map illustrates the fold change 289 of arn Ecl , phoPQ Ecl , and pmrAB Ecl gene expression in the TCS mutants relative to wild type (Fig  290   4 ). Expression of the arn Ecl genes were significantly down regulated in ∆phoPQ Ecl compared to 291 wild type, suggesting that activation of the pathway is dependent on PhoPQ Ecl . In contrast, arn Ecl 292 gene expression was not significantly altered in the ∆pmrAB Ecl mutant relative to wild type. 293
Together the transcriptomic analysis ( Fig 4) and colistin heteroresistance in wild type E. cloacae 296 ( Fig 1A and Table 1 ) suggest constitutive addition of L-Ara4N to lipid A in a subset of the 297 population under standard growth conditions. In E. coli and Salmonella, PhoPQ is activated by 298 various signals, including low Mg 2+ and CAMPs (13, 23, 25). PhoP activates PmrAB, which 299 stimulates pEtN and L-Ara4N addition to lipid A (27). Here we analyzed if PhoPQ Ecl responds to 300 similar physiological cues to induce colistin resistance in E. cloacae. Wild type and mutant E. 301 cloacae were grown in N minimal medium with high (10 mM) or low (10 µM) Mg 2+ levels. All 302 cultures were exposed to colistin at mid-logarithmic growth. Wild type and complemented 303 phoPQ Ecl mutant strains grown in high Mg 2+ demonstrated some susceptibility to 5 and 10 µg/ml 304 of colistin ( Fig 5A, High Mg 2+ ), suggesting colistin-susceptible and -resistant populations were 305 present. When grown under limiting Mg 2+ conditions, E. cloacae cells were resistant ( Fig 5A,  306 Low Mg 2+ ). The phoPQ Ecl mutant demonstrated a fitness defect in either Mg 2+ concentration 307 when exposed to colistin ( Fig 5A) . These data suggest that PhoPQ Ecl induces colistin resistance 308 in response to limiting Mg 2+ growth conditions. 309 310
PhoPQ Ecl responds to limiting Mg 2+ conditions by inducing L-Ara4N lipid A modification. 311
To determine if increased colistin resistance was dependent on L-Ara4N modification of lipid A, 312
we isolated lipid A after growth in either low or high Mg 2+ . TLC analysis demonstrated that wild 313 type and the complemented phoPQ Ecl mutant primarily produced L-Ara4N-modified lipid A 314 when Mg 2+ concentrations were limiting ( Fig 5B, Low Mg 2+ ). In contrast, the same strains grown 315 in excess Mg 2+ , produced a mixture of modified and unmodified lipid A (Fig 5B, High Mg 2+ ). 316
Interestingly, growth in excess Mg 2+ does not completely shut-off production of PhoPQ Ecl -observe a decrease in the relative amount of the di-L-Ara4N form while increasing the ratio of 319 unmodified lipid A species ( Fig 5B) . Together, these studies suggest that a subset of the clonal E. 320 cloacae population activates PhoPQ Ecl -dependent L-Ara4N of lipid A under standard growth 321 conditions. However, depletion of Mg 2+ induces PhoPQ Ecl signaling to enhance L-Ara4N 322 modification ( Fig 5B) and colistin resistance ( Fig 5A) a key regulatory checkpoint, which likely promotes constitutive arn Ecl transcription and L-Ara4N 344 modification of lipid A in a subset of the clonal E. cloacae population. Since selection has driven 345 E. cloacae and other ECC to maintain an altered lipid A modification signaling network, we 346 predict that it is advantageous to maintain a CAMP resistant subpopulation in some 347 environments. Presumably, the alternative regulatory mechanism promotes bacterial fitness in 348 environments specific to its commensal and pathogenic niches. All strains and plasmids used in this study are listed in Table S1 . Briefly, E. cloacae subsp. 366 cloacae 13047 mutant strains were constructed as previously described using recombineering 367 with the plasmid pKOBEG (49). Linear PCR products were introduced in to the E. cloacae 368 ATCC 13047/pKOBEG strain by electroporation and plated on selective media. Selected clones 369 were transformed with pCP20 to cure the antibiotic resistance cassette. 370
To complement E. cloacae mutants, the coding sequence from phoPQ Ecl MICs of colistin were determined in triplicate by the broth microdilution (BMD) method. Briefly 386 strains were inoculated from overnight cultures at an OD 600 = 0.1. Various concentrations (0 -387 256 µg/ml) of colistin were added to each well and cultures were incubated overnight. Growth 388 was indicated by a reading the OD 600 and the lowest concentration at which growth was inhibited 389 was recorded as the MIC. E. coli W3110 and WD101 were used as control strains. In some 390 cases, 'skip wells' were observed suggesting a heteroresistance phenomenon and the MIC was 391 determined disregarding the clear wells (35) . 392 393
Population Analysis 394
Population analysis profiling was performed by plating a high inoculum (1 X 10 10 CFU) onto LB 395 agar containing 1 to 64 µg/ml colistin (in 2-fold increments). Plates were incubated overnight at 396 37° C and frequency of the subpopulation was determined by dividing by the total number of 397 cells (50). 398 399
Isolation of Lipid A 400
Isolation of lipid A for TLC analysis involved 32 P-radiolabeling of whole cells was performed as 401 previously described with slight modifications (51) . In brief, 12.5 ml of E. cloacae was grown at 402 37° C to OD 600 = 1.0. Bacteria were harvested by centrifugation at 10,000 X g for 10 min. Lipid 403
A extraction was carried out by mild-acid hydrolysis as previously described (52). Polymyxin E survival assay analysis were performed as previously described with slight 425 modifications (27). Wild type and mutant E. cloacae strains were grown overnight on LB agar. 426
The following day, media N minimal medium with pH = 7.5, 10 µM MgSO 4 were inoculated at 427 OD 600 = 0.1 with bacteria from overnight cultures that were washed with N minimal media 428 without Mg 2+ or iron. Cultures were grown until OD 600 = 0.6, when they were split and treated 429 with 0, 5 or 10 µg/ml of colistin (Polymyxin E). Cultures were incubated for 1 h at 37° C and 430 then colony-forming units were plated and calculated. Percent survival was calculated by dividing the number of bacteria after treatment with colistin relative to those incubated in the 432 absence of colistin and then multiplied by 100. 433 434
Protein Purification 435
To purify the PhoP Ecl protein, the coding sequence was cloned into pT7-7Kn, as previously 436 described (7). Briefly the phoP Ecl CDS was amplified from E. cloacae cDNA with primers that 437 added a C-terminal His 8X tag. From an overnight starter culture, 1 Liter of LB broth containing 438 25 µg/ml of kanamycin was inoculated at 1:50 and grown at 37° C until the OD 600 = 0.5. IPTG 439 was added to a final concentration of 1mM, and the culture was incubated at 37° C for an 440 additional 4 h. Bacteria were recovered by centrifugation at 10,000 x g for 10 min, and the 441 bacteria were resuspended in lysis buffer. Bacteria were lysed using sonication and the soluble 442 fraction was recovered by centrifugation at 10,000 x g for 30 min. PhoP Ecl -His 8X was purified on 443 a Ni-nitrilotriacetic acid (NTA) beads according to the manufactures instructions (Qiagen). 444 445
Electrophoretic Mobility Shift Assay 446
PhoP Ecl -His 8X proteins were purified as described above. EMSAs were performed based on a 447 modified protocol (6). 250-bp DNA fragments of phoP Ecl ratio of mutant to wild type expression (P <0.05). 664 Wild type ≥256* 0.125** 9.5 X 10 -3 6.3 X 10 -2 5.2 X 10 -3 7.5 X 10 -3 7.6 X 10 -2 6.3 X 10 - 
Figure 5: PhoPQ Ecl -dependent activation of l-Ara4N addition induces colistin resistance in low
